1. 1-24 of 214 1 2 3 4 5 6 7 8 9 »
    1. No, Amazon Is Not Buying Target, Kohl's, or Any Other Retailer

      No, Amazon Is Not Buying Target, Kohl's, or Any Other Retailer

      Amazon.com 's (NASDAQ: AMZN) $13.7 billion acquisition of Whole Foods Market shook up the retail sector, stunning investors and sending supermarket stocks plunging. Indeed, it was a surprising move and indicated a new direction for Amazon, but the worst lesson investors seemed to take from the deal is that it immediately conveyed value on all other brick-and-mortar retailers as if they could be the next targets of Amazon...

      Read Full Article
    2. miRagen Therapeutics Expands Board of Directors with Appointment of Arlene Morris

      miRagen Therapeutics Expands Board of Directors with Appointment of Arlene Morris

      Ms. Morris has extensive experience in the pharmaceutical and biotechnology industries serving in numerous executive management and board roles. Her appointment increases miRagen's Board from seven directors to eight directors . "With more than 25 years of exceptional leadership experience in ...

      Read Full Article
    3. AIT Therapeutics Appoints Yoori Lee to its Board of Directors

      AIT Therapeutics Appoints Yoori Lee to its Board of Directors

      Ms. Yoori Lee, Co-Founder and President of Trio Health Advisory Group noted, "After reviewing AIT's accomplishments and the opportunities that lie ahead, I am pleased to join this dynamic company's Board of Directors . Given the very high probability of near-term success for the company's nitric oxide ...

      Read Full Article
    4. Veteran Financial Expert Rejoins Superconductor Technologies Board of Directors

      Veteran Financial Expert Rejoins Superconductor Technologies Board of Directors

      Accordingly, STI's board will continue to have four members. Mr. Quiram added, "I would like to thank Dan for his many valuable contributions during his tenure on the board of directors . We wish him well as he pursues his new, exciting opportunity." David Vellequette most recently served as Senior Vice ...

      Read Full Article
    5. Ruby Tuesday Board of Directors Rejects Highly-Conditional and Not Fully-Financed Acquisition

      Ruby Tuesday Board of Directors Rejects Highly-Conditional and Not Fully-Financed Acquisition

      The Board of Directors thoroughly evaluated Boaz's most recent proposal, including seeking clarifications from Boaz on the proposal, and unanimously determined that the proposal did not constitute and would not reasonably be expected to lead to a superior proposal as compared to the acquisition by ...

      Read Full Article
    6. Sarepta Therapeutics Elects Biopharmaceutical Veteran, Michael W. Bonney, to its Board of Directors

      Sarepta Therapeutics Elects Biopharmaceutical Veteran, Michael W. Bonney, to its Board of Directors

      "Sarepta and its board of directors are greatly enhanced with the appointment to our board of Mike Bonney, one of the most respected biopharmaceutical leaders," said M. Kathleen Behrens, Ph.D., chair of Sarepta's board of directors . "Mike's list of accomplishments is long and his impact on this industry ...

      Read Full Article
    7. RBR seeks Saudi Royal Family Investment for Credit Suisse

      RBR seeks Saudi Royal Family Investment for Credit Suisse

      (Reuters) - Activist investor RBR Capital Advisors has offered to connect Credit Suisse with the Saudi royal family as potential major shareholders for the Swiss bank, a person familiar with the matter told Reuters. The Swiss hedge fund led by Rudolf Bohli, which has a stake in Credit Suisse, last month pushed for a break up of the bank into three parts, hoping to double its market value...

      Read Full Article
    1-24 of 214 1 2 3 4 5 6 7 8 9 »
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content